These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 9391776)
1. Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management. Warkentin TE Drug Saf; 1997 Nov; 17(5):325-41. PubMed ID: 9391776 [TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia: a ten-year retrospective. Warkentin TE Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268 [TBL] [Abstract][Full Text] [Related]
3. The approach to heparin-induced thrombocytopenia. Linkins LA; Warkentin TE Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088 [TBL] [Abstract][Full Text] [Related]
4. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia. Lubenow N; Greinacher A Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002 [TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Warkentin TE Transfus Med Rev; 1996 Oct; 10(4):249-58. PubMed ID: 8899954 [TBL] [Abstract][Full Text] [Related]
6. Agents for the treatment of heparin-induced thrombocytopenia. Warkentin TE Hematol Oncol Clin North Am; 2010 Aug; 24(4):755-75, ix. PubMed ID: 20659659 [TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Warkentin TE; Elavathil LJ; Hayward CP; Johnston MA; Russett JI; Kelton JG Ann Intern Med; 1997 Nov; 127(9):804-12. PubMed ID: 9382401 [TBL] [Abstract][Full Text] [Related]
8. An overview of the heparin-induced thrombocytopenia syndrome. Warkentin TE Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649 [TBL] [Abstract][Full Text] [Related]